{
    "clinical_study": {
        "@rank": "100866", 
        "arm_group": {
            "arm_group_label": "autologous skin fibroblasts", 
            "arm_group_type": "Experimental"
        }, 
        "brief_summary": {
            "textblock": "This research is being done to determine if we can change skin from one type to another.\n      Specifically, we are interested in making normal skin into the thicker skin found on our\n      palms and soles."
        }, 
        "brief_title": "Feasibility Study for Fibroblast Autologous Skin Grafts", 
        "completion_date": {
            "#text": "December 2017", 
            "@type": "Anticipated"
        }, 
        "condition": "Wounds and Injuries", 
        "condition_browse": {
            "mesh_term": "Wounds and Injuries"
        }, 
        "detailed_description": {
            "textblock": "To change the skin identity we propose to take skin cells from a person's own sole or palm\n      (these are called \"autologous skin fibroblasts\"), multiply them in the lab, inject the cells\n      (now called a \"graft\") back into the same person but at a different site of skin like the\n      buttock, and then eventually remove the injected cells to see if they caused the skin to\n      change.\n\n      We hope that information from this study will help with problems like skin break-down in\n      patients with amputations and prosthetics.  The skin at their stump was not meant to\n      withstand the pressure and friction of prosthetics and this study is the first step in\n      trying to convert stump skin to palm/sole-like skin."
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  may be male or female\n\n          -  must be between 18 years and 65 years of age\n\n          -  must be medically able to undergo the administration of study material determined by\n             laboratory tests obtained 2 weeks before baseline for which the investigator\n             identified no significant abnormality\n\n          -  provide informed consent for participation\n\n          -  females of childbearing potential must: have a negative pregnancy test at screening,\n             agree not be become pregnant or breastfeed for the period of the study, be willing to\n             use reliable form of contraception during the study\n\n          -  be willing to comply with the scheduled visits, biopsy/injection procedures, wound\n             care insturctions, and treatment plan.\n\n        Exclusion Criteria:\n\n          -  received any investigational drug within 30 days prior to study entry\n\n          -  an allergy history to any study materials including anesthetic, antibiotics,\n             antimycotics, dimethyl sulfoxide, human albumim, bovine constituents, hetastarch,\n             penicillin, streptomycin, amphotericin\n\n          -  pregnant, lactating, or trying to become pregnant\n\n          -  history of keloid formation\n\n          -  an active wound\n\n          -  significant medical history of infectious disease (HIV, HTLV I/II, hepatitis B,\n             hepatitis C), autoimmune conditions, cancer\n\n          -  current skin disease (eczema, psoriasis, lichen planus)\n\n          -  diagnosis of uncontrolled diabetes\n\n          -  active smoker\n\n          -  use of chronic immunosuppresive therapies such as oral and topical steroids."
            }, 
            "gender": "Both", 
            "healthy_volunteers": "Accepts Healthy Volunteers", 
            "maximum_age": "65 Years", 
            "minimum_age": "18 Years"
        }, 
        "enrollment": {
            "#text": "20", 
            "@type": "Anticipated"
        }, 
        "firstreceived_date": "October 15, 2013", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT01964859", 
            "org_study_id": "NA_00068684", 
            "secondary_id": "1R01AR064297-01A1"
        }, 
        "intervention": {
            "arm_group_label": "autologous skin fibroblasts", 
            "intervention_name": "autologous skin fibroblasts", 
            "intervention_type": "Biological"
        }, 
        "is_fda_regulated": "Yes", 
        "is_section_801": "Yes", 
        "keyword": [
            "healthy skin", 
            "wounds and injuries", 
            "prosthetics", 
            "amputations", 
            "dermal fibroblasts"
        ], 
        "lastchanged_date": "October 15, 2013", 
        "location": {
            "contact": {
                "email": "ctrep@jhmi.edu", 
                "last_name": "Sherry Leung", 
                "phone": "410-502-7546"
            }, 
            "facility": {
                "address": {
                    "city": "Baltimore", 
                    "country": "United States", 
                    "state": "Maryland", 
                    "zip": "21287"
                }, 
                "name": "Johns Hopkins School of Medicine, Dermatology Department"
            }, 
            "investigator": {
                "last_name": "Luis Garza, MD, PhD", 
                "role": "Principal Investigator"
            }, 
            "status": "Not yet recruiting"
        }, 
        "location_countries": {
            "country": "United States"
        }, 
        "number_of_arms": "1", 
        "official_title": "Feasibility Study for Fibroblast Autologous Skin Grafts: Biopsy of Skin Fibroblasts, Expansion in Cell Therapy Core, Topical Injection of Fibroblasts, and Subsequent Removal of Graft for Laboratory Studies.", 
        "overall_contact": {
            "email": "ctrep@jhmi.edu", 
            "last_name": "Sherry Leung", 
            "phone": "410-502-7546"
        }, 
        "overall_official": {
            "affiliation": "Department of Dermatology, Johns Hopkins School of Medicine", 
            "last_name": "Luis Garza, MD, PhD", 
            "role": "Principal Investigator"
        }, 
        "overall_status": "Not yet recruiting", 
        "oversight_info": {
            "authority": "United States: Food and Drug Administration", 
            "has_dmc": "Yes"
        }, 
        "phase": "Phase 1", 
        "primary_completion_date": {
            "#text": "December 2015", 
            "@type": "Anticipated"
        }, 
        "primary_outcome": {
            "description": "epidermal thickening in sites of injection of volar fibroblasts determined by non-invasive imaging", 
            "measure": "thickened epidermis", 
            "safety_issue": "No", 
            "time_frame": "6 months"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT01964859"
        }, 
        "responsible_party": {
            "investigator_affiliation": "Johns Hopkins University", 
            "investigator_full_name": "Luis Garza, MD-PhD", 
            "investigator_title": "Assistant Professor, Department of Dermatology, Johns Hopkins School of Medicine", 
            "responsible_party_type": "Principal Investigator"
        }, 
        "source": "Johns Hopkins University", 
        "sponsors": {
            "collaborator": [
                {
                    "agency": "National Institutes of Health (NIH)", 
                    "agency_class": "NIH"
                }, 
                {
                    "agency": "National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)", 
                    "agency_class": "NIH"
                }, 
                {
                    "agency": "Department of Defense", 
                    "agency_class": "U.S. Fed"
                }
            ], 
            "lead_sponsor": {
                "agency": "Johns Hopkins University", 
                "agency_class": "Other"
            }
        }, 
        "start_date": "January 2014", 
        "study_design": "Endpoint Classification: Safety/Efficacy Study, Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Basic Science", 
        "study_type": "Interventional", 
        "verification_date": "October 2013"
    }
}